학술논문

Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis.
Document Type
article
Source
Virology. 382(2)
Subject
Liver
Brain
Killer Cells
Natural
Animals
Mice
Inbred C57BL
Mice
Knockout
Mice
Murine hepatitis virus
Encephalitis
Viral
Hepatitis
Viral
Animal
Coronavirus Infections
Homeodomain Proteins
Virus Replication
Recombination
Genetic
Amino Acid Sequence
Base Sequence
Genome
Viral
Chemokine CXCL9
Immunity
Innate
Rare Diseases
Chronic Liver Disease and Cirrhosis
Infectious Diseases
Digestive Diseases
Liver Disease
Neurosciences
Hepatitis
Emerging Infectious Diseases
Aetiology
2.1 Biological and endogenous factors
Infection
Good Health and Well Being
Chemokines
Virus
Central nervous system
Host defense
Biological Sciences
Agricultural and Veterinary Sciences
Medical and Health Sciences
Virology
Language
Abstract
The role of the CXC chemokine ligand 9 (CXCL9) in host defense following infection with mouse hepatitis virus (MHV) was determined. Inoculation of the central nervous system (CNS) of CXCL9-/- mice with MHV resulted in accelerated and increased mortality compared to wild type mice supporting an important role for CXCL9 in anti-viral defense. In addition, infection of RAG1-/- or CXCL9-/- mice with a recombinant MHV expressing CXCL9 (MHV-CXCL9) resulted in protection from disease that correlated with reduced viral titers within the brain and NK cell-mediated protection in the liver. Survival in MHV-CXCL9-infected CXCL9-/- mice was associated with reduced viral burden within the brain that coincided with increased T cell infiltration. Similarly, viral clearance from the livers of MHV-CXCL9-infected mice was accelerated but independent of increased T cell or NK cell infiltration. These observations indicate that CXCL9 promotes protection from coronavirus-induced neurological and liver disease.